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Abstract
Cancer has been described as the second leading causes of death
worldwide estimating 8.2 million deaths in 2012. In the same year,
14.1 million new cases were diagnosed globally with an expected
increased rate at 11% according to the data given by GLOBOCAN
and WHO. Its diagnosis and targeted treatment is still a mystery for
the scientific communities. A drastic increase has been seen in the estab-
lishment of cancer research and treatment centers around theworld dur-
ing the last two decades. In spite of having tens of thousands of cancer
treatment and research centers, this mystery cannot be resolved. Up to
now, it has been proposed that cancermaynot be curable but preventable
as more than 90% cancers are caused by environmental factors. Natural
foods and physical activities are the significant approaches in cancer
prevention. Other recommendations based on the WCRF/AICR find-
ings, report focusing on the improvements in social life, smoking cessa-
tion, diet changes, early detection and state-of-the-art treatment (http://
www.wcrf.org). Cancer awareness, consultation to patient’s family and
early detectionmay help to savemany lives. It is the necessity of time to
increase focus on the development and implementation of effective
preventive strategies. A strategic social integrated model for cancer
prevention focusing the social integration of multidisciplinary fields is
required to stop cancer spreading. Cancer prevention centres should
be established to gather the communities working on cancer in
different directions because cooperation of bright minds can lead to a
better prevention and these centers should provide a platform for
oncologists, policy makers, consultants, surgeons, radiologists,
molecular biologists and pathologists, to draw preventive strategies
because better coordination is better prevention.
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Deaths caused by cancer are rising in the world and it has been
estimated that nearly 10 million persons are died because of cancer
till now. Non-invasive approaches of cancer diagnosis is the hot topic
of current decade and a number of new diagnostic approaches like
detection of circulating tumor cells (CTCs), circulating tumor DNA
(ctDNA) etc from cancer patients and analysing the tumor size, stage
and even the types is under investigation. It also has been proposed
that cancer spreading can be stopped by implementing efficient can-
cer prevention strategies. According to WCRF/AICR recommenda-
tions, more than 90% cancers can be prevented if we do
improvements in social life style, smoking cessation, diet changes,
early detection and state-of-the-art treatment (http://www.wcrf.org).
Nastaran Center for Cancer Prevention (NCCP) was established in
2014 in Mashhad, Iran to draw and implement efficient cancer
prevention strategies and to achieve this aim. NCCP established a
platform of peoples in which we tried to gather peoples from all
fields of science and society such as cancer therapists, genetics
experts, psycho-oncologists, cell and molecular biologists, policy
makers, molecular pathologists and etc. Nastaran Symposium-2015
is the first international cancer symposium organized by NCCP in
collaboration with Ferdowsi University of Mashhad and Mashhad
University of Medical Sciences (MUMS), Mashhad, Iran. This
symposium was aimed to discuss the issues in cancer prevention
and diagnosis. One session was also included as targeted and novel
therapeutic approaches to treat cancer and it was discussed that
cancer prevention should be focused on three steps, primary
prevention, secondary prevention and tertiary prevention. NCCP is
also working for the upcoming Nastaran Symposium-2016 as the
2nd International Nastaran Cancer Symposium-2016 held in
October of 2016.
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sium-2015, Nastaran Symposium-2016, Nastaran Center for Cancer
Prevention, Mashhad-Iran.
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Extended Abstract
Introduction: One hundred years ago, we ate beneficial bacteria
all the time but pasteurization, sterilization and irradiation of food
have ended much of that. The concept of probiotics evolved at the
Fig. 1. Mechanism of action of probiotics during colon cancer progression.
Fig. 2. The most commonly used species of lactic acid bacteria in probiotic
preparations.
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Nobel Prize-winning Russian scientist Elie Metchnikoff, who pro-
pounded that the long and healthy life of Bulgarian people resulted
from their consumption of fermented milk products. Probiotic food
can be defined as “food containing live microorganisms believed to
actively enhance health by improving the balance of microflora in
the gut”. A number of health benefits have been claimed for probiotic
bacteria such as Lactobacillus acidophilus, Bifidobacterium spp., and
Lactobacillus casei. Because of the potential health benefits, these
organisms are increasingly incorporated into dairy foods.
Molecular study: Increasingly, the microbiological scientific
community is relying on molecular biology to define the complexity
of the gut flora and to distinguish one organism from the next. Current
techniques, including genetic fingerprinting, gene sequencing, oligo-
nucleotide probes and specific primer selection, discriminate closely
related bacteria with varying degrees of success. Additional molecu-
lar methods being employed to determine the constituents of complex
microbiota in this area of research are community analysis, denatur-
ing gradient gel electrophoresis (DGGE)/temperature gradient gel
electrophoresis (TGGE), fluorescent in situ hybridisation (FISH)
and probe grids.
Cancer: Cancer is a serious global public health problem. There
are several epidemiological evidences that support a protective role
of probiotics against cancer. Probiotic bacteria are known to exert
an anticancer activity in animal studies. Lactic acid bacteria and their
probioactive cellular substances exert many beneficial effects in the
gastrointestinal tract, and also release various enzymes into the intes-
tinal lumen and exert potential synergistic (LAB) effects on digestion
and alleviate symptoms of intestinal malabsorption. A carcinogen is
any substance, radionuclide, orradiation that is an agent directly
involved in causing cancer. This may be due to the ability to damage
thegenome or to the disruption of cellularmetabolic processes.
Colon cancer: Colon cancer is the second to third most frequent
type of cancer in Western industrialized countries. Environmental fac-
tors, such as living in an industrialized area, physical inactivity, expo-
sure to certain chemicals and consumption of a high fat, low fiber
diet, are of greater interest because they represent controllable risk
factors. Within the complex gut microflora, which consists of >1
1011 living bacteria/g colon content, LAB belong to those bacteria
with such beneficial effects investigated for possible use as probiotics
and for colon cancer biological products. Five of these strains
inhibited growth of eight food-borne pathogens including Helico-
bacter pylori, Escherichia coliand Salmonella typhimurium. Several
mechanisms have been proposed as to how LAB may inhibit colon
cancer, including enhancing the host’s immune response, altering
the metabolic activity of the intestinal microbiota, binding and
degrading carcinogens, producing antimutagenic compounds, and
altering the physiochemical conditions in the colon. It appears that
LAB can reduce the levels of colon enzymes that convert pro-carci-
nogens to carcinogens. Specifically, LAB can reduce levels of the
enzymes b-glucuronidase, nitro-reductase, and azo-reductase (Kamp-
manet al. 1994). Most animal and human studies do indicate that
feeding certain LAB decreases fecal enzyme levels that may be
involved in formation of carcinogens. Also, beneficial effects can
be attributed to immune-potentiating effects by LAB strains. One spe-
cific effect was shown by heat-killed Lactobacillus plantarum L-137,
which restored the inhibited IL-12 production in DBA/2 mice with
tumors. The anti-tumor effects were found to be due to the activation
of macrophage by LC9018.
Breast cancer: Results of cross-cultural and regional correlation
studies have shown that breast cancer mortality correlates positivelywith the consumption of milk products. Milk fermented by B. infan-
tis, B. bifidum, B. animalis, L. acidophilus and L. paracasei inhibited
the growth of the MCF7 breast cancer cell line, and the antiprolifer-
ative effect was not related to the presence of bacteria. Isoflavones are
a class of phytoestrogens plant-derived compounds with estrogenic
activity. Soybeans and soy products are the richest sources of isofla-
vones in the human diet. Soy phytoestrogens were suggested to
reduce the risk of a number of diseases including breast cancer. Given
that these compounds are metabolized by bacteria, alteration of intes-
tinal bacteria and enzymes may affect phytoestrogen metabolism.
Observational studies suggest that dietary isoflavones reduce breast
cancer risk, and this may be caused in part by effects on endogenous
hormone concentrations. Because intestinal bacteria metabolize iso-
flavones, it was hypothesized that consumption of probiotic bacteria
would enhance the biologic effects of isoflavones, including effects
on endogenous hormones.
Bladder cancers: Few human clinical trials were conducted, and
one showed that L. casei consumption (three times per day for 1 year)
increased the recurrence free period among subjects with bladder can-
cer. Daily intake of a viable L. casei strain postponed recurrence of
bladder tumors in a randomized, controlled, multicenter study in 48
Japanese patients. Patients were enrolled within 2 wk after removal
of one or more bladder tumors. One hypothesis for the prevention
or delay of tumor development by lactobacilli is that they might
bind to mutagenic compounds in the intestine.
Liver cancer: Liver cancer is the sixth most commonly diagnosed
cancer in the world, and the third most common cause of death from
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shown to attenuate hepatotoxic effects of aflatoxin, a well known liver
carcinogen, in rats and to reduce biomarkers of liver cancer risk in a
human intervention trial. Probiotic bacteria could block the intestinal
absorption of aflatoxin B1 and thereby lead to reduced urinary excre-
tion of aflatoxin B1-N
7-guanine (AFB-N7-guanine), a marker for a
biologically effective dose of aflatoxin exposure. Elevated urinary
excretion of this aflatoxin-DNA adduct is associated with an
increased risk of liver cancer.
Conclusion: The probiotic theory offers an intriguing approach to
controlling negative metabolic or pathogenic activities of microbes to
which we are exposed on a daily basis. Results suggest that consump-
tion of a high amount of fermented milk products may have a protec-
tive effect on the risk of cancer.
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Extended Abstract
Introduction: Gastric cancer (GC) is the most common malig-
nancy and the second cause of cancer death worldwide which is
often diagnosed in advanced stages. GC is a highly heterogeneous
and multistep disease due to deregulation of common oncogenic
pathways. Helicobacter pylori infection, diet, alcohol consumption,
and smoking are main environmental risk factors for GC. The
World Health Organization International Agency for Research on
Cancer (WHO/IARC, 69372 Lyon CEDEX 08, France) has intro-
duced Helicobacter pylori as the first group of carcinogens. It is
reported that Helicobacter pylori infection is associated with
chronic inflammation and can induce chronic gastritis, intestinal
metaplasia, intestinal dysphasia, and also GC. MicroRNAs (miR-
NAs) are a large class of short non-coding RNAs (containing about
22 nucleotides) which have critical role in regulation of oncogenes,
tumor suppressors, and cancer-related genes controlling cell cycle,
apoptosis, cell migration, and angiogenesis. Therefore, miRNAs
can be utilized as a prognostic biomarker and also therapeutic tar-
gets for treatment strategy. The role of miR-342-3p has been
defined in cervical, colorectal, breast cancers, and hepatocellular
carcinoma (HCC). It significantly inhibits HCC cell proliferation
via NF-kB pathway. Moreover, miR-342-3p inhibits cell prolifera-
tion, migration, and invasion in cervical cancer cell lines. InTable 1 Enrichment analysis of miR342-3p targetome.
Pathway Count (Gene no.) Enrichment p value
Pathway in cancer 11 3.9E-5
JAK-STAT 6 4.6E-2addition, it may act as a tumor suppressor gene in colorectal cancer
development. However, the probable role of miR-342-3p in gastric
carcinogenesis is unknown. This study aimed to expand current
knowledge of probable molecular function of miR-342-3p in
patients with GC by using bioinformatics tools.
Methods: Predicted and validated targets of miR-342-3p were
obtained from miRwalk (a comprehensive atlas of microRNA-target
interactions, http://zmf.umm.uni-heidelberg.de/apps/zmf/mirwalk2/)
and miRTarBase (experimentally validated microRNA-target
interactions database, http://mirtarbase.mbc.nctu.edu.tw/) databases
respectively. The expression patterns of targetable genes in normal
stomach and gastrointestinal tumor were investi
gated by UniGene (http://www.ncbi.nlm.nih.gov/unigene/term)
database. Finally, GC specific targetome were classified into
molecular pathways by DAVID (database for annotation,
visualization and integrated discovery, https://david.ncifcrf.gov/
home.jsp) database.
Results: MiR-342-3p targetome manifested “pathway in can-
cer” as the most statistical relevant pathway (Table 1). It is pre-
dicted that critical mRNAs in angiogenesis pathway including,
TGFa, EGFR, Grb2, SOS, Raf, MEK, ERK, cJun, Ets1, VEGEF,
and MMPs are targeted by miR-342-3p. Interestingly, our data
showed that miR-342-3p inhibits some well-known oncogenes
such as JAK, SHP2, STAT, GRB, SOS, and BclXL in “JAK-STAT
pathway” which is one of the inflammation-related signaling
pathways.
Conclusion: Chronic inflammation is an important risk factor for
GC with approximately 25% of all gastric carcinoma worldwide.
Adherence of Helicobacter pylori to gastric epithelial cells has
been shown to trigger several signaling pathways. NF-kB and
JAK/STAT are the two most remarkable inflammation-related signal-
ing pathway. NF-kB is one of the major transcription factors that
regulate the expression of genes involved in inflammation, cell pro-
liferation, differentiation, and apoptosis. The Janus kinase/signal
transducers and activators of transcription (JAK/STAT) has critical
role in inflammation signaling immune system, and cytokine-cyto-
kine interaction pathways in various kind of cells. Boram Cha et
al. showed that JAK1/STAT3 is upstream signaling effectors of
NF-kB in Helicobacter pylori-infected gastric epithelial cells. More-
over, some studies have suggested that JAK/STAT may play an
important role in expansion of gastric carcinoma. In addition, Boram
Cha et al. found that inhibition of Jak1/Stat3 may be beneficial for
the treatment of Helicobacter pylori-induced gastric inflammation.
According to our data, miR-342-3p acts as a tumor suppressor mol-
ecule and may be involved in GC carcinogenesis by altering regula-
tion of angiogenesis and some GC-related pathways. More
specifically, our data proposed a probable strong correlation between
miR-342-3p and NF-kB and JAK/STAT signaling pathways based on
in-depth in silico investigation. However, clarification on the exact
function of miR-342-3p needs real laboratory procedure. To sum it
up, miR-342-3p might be a useful prognostic biomarker in GC
patients.Target gene
TGFa, EGFR, Grb2, SOS, Raf, MEK, ERK, cJun, Ets1, VEGEF and MMPs
JAK, SHP2, STAT, GRB, SOS, BclXL
